Na+/H+ exchanger isoform 1-induced osteopontin expression facilitates cardiomyocyte hypertrophy

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Mohamed, Iman A ^a   Gadeau, Alain Pierre ^b   Fliegel, Larry ^c   Lopaschuk, Gary ^c   Mlih, Mohamed ^a   Abdulrahman, Nabeel ^a   Fillmore, Natasha ^c   Mraiche, Fatima ^a  

^a Qatar University ^*  (Qatar)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OSTEOPONTIN; PROTEIN KINASE B; S6 KINASE; SMALL INTERFERING RNA; SODIUM PROTON EXCHANGE PROTEIN 1; TRANSCRIPTION FACTOR GATA 4; SLC9A1 PROTEIN, RAT; SODIUM PROTON EXCHANGE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENETIC TRANSFECTION; HEART HYPERTROPHY; HEART MUSCLE CELL; IN VITRO STUDY; NEWBORN; NONHUMAN; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; UPREGULATION; ANIMAL; CARDIAC MUSCLE CELL; CARDIOMEGALY; CELL CULTURE; CELL ENLARGEMENT; GENETICS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ADENOVIRIDAE;

ANIMALS; CARDIOMEGALY; CELL ENLARGEMENT; CELLS, CULTURED; MYOCYTES, CARDIAC; OSTEOPONTIN; PHOSPHORYLATION; RATS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SODIUM-HYDROGEN ANTIPORTER; TRANSFECTION;

EID: 84928791241     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0123318     Document Type: Article

References (66)

1. - (2013) World Health Organization. Cardiovascular Diseases (CVDs). Media Center: World Health Organization.
2. Kehat I, Molkentin JD (2010) Molecular pathways underlying cardiac remodeling during pathophysiological stimulation. Circulation 122: 2727-2735. doi: 10.1161/CIRCULATIONAHA.110.942268 PMID: 21173361
3. Marian AJ, Willerson JT, Wellens HJJ, Cohn JN, Holmes DR (2007) Cardiac Hypertrophy. Cardiovascular Medicine: Springer London. pp. 1177-1188.
4. Fliegel L (2009) Regulation of the Na(+)/H(+) exchanger in the healthy and diseased myocardium. Expert Opin Ther Targets 13: 55-68. doi: 10.1517/14728220802600707 PMID: 19063706
5. Xue J, Mraiche F, Zhou D, Karmazyn M, Oka T, Fliege L, et al. (2010) Elevated myocardial Na+/H+ exchanger isoform 1 activity elicits gene expression that leads to cardiac hypertrophy. Physiol Genomics 42: 374-383. doi: 10.1152/physiolgenomics.00064.2010 PMID: 20460605
6. Voelkl J, Pasham V, Ahmed MS, Walker B, Szteyn K, Kuhl D, et al. (2013) Sgk1-dependent stimulation of cardiac na/h(+) exchanger nhe1 by dexamethasone. Cell Physiol Biochem 32: 25-38. doi: 10.1159/000350120 PMID: 23860121
7. Huber JD, Bentzien J, Boyer SJ, Burke J, De Lombaert S, Eickmeier C, et al. (2012) Identification of a potent Sodium Hydrogen Exchanger isoform 1 (NHE1) inhibitor with a suitable profile for chronic dosing and demonstrated cardioprotective effects in a preclinical model of myocardial infarction in the rat. J Med Chem.
8. Malo ME, Fliegel L (2006) Physiological role and regulation of the Na+/H+ exchanger. Can J Physiol Pharmacol 84: 1081-1095. PMID: 17218973
9. Coccaro E, Mraiche F, Malo M, Vandertol-Vanier H, Bullis B, Robertson M, et al. (2007) Expression and characterization of the Na+/H+ exchanger in the mammalian myocardium. Mol Cell Biochem 302: 145-155. PMID: 17431747
10. Kilic A, Velic A, De Windt LJ, Fabritz L, Voss M, Mitko D, et al. (2005) Enhanced activity of the myocardial Na+/H+ exchanger NHE-1 contributes to cardiac remodeling in atrial natriuretic peptide receptordeficient mice. Circulation 112: 2307-2317. PMID: 16216978
11. Mraiche F, Fliegel L (2011) Elevated expression of activated Na(+)/H(+) exchanger protein induces hypertrophy in isolated rat neonatal ventricular cardiomyocytes. Mol Cell Biochem 358: 179-187. doi: 10. 1007/s11010-011-0933-z PMID: 21720766
12. Shibata M, Takeshita D, Obata K, Mitsuyama S, Ito H, Zhang GH, et al. (2011) NHE-1 participates in isoproterenol-induced downregulation of SERCA2a and development of cardiac remodeling in rat hearts. Am J Physiol Heart Circ Physiol 301: H2154-2160. doi: 10.1152/ajpheart.00483.2011 PMID: 21856903
13. Ennis IL, Escudero EM, Console GM, Camihort G, Dumm CG, Seidler RW, et al. (2003) Regression of isoproterenol-induced cardiac hypertrophy by Na+/H+ exchanger inhibition. Hypertension 41: 1324-1329. PMID: 12732584
14. Karmazyn M (2013) NHE-1: still a viable therapeutic target. J Mol Cell Cardiol 61: 77-82. doi: 10.1016/ j.yjmcc.2013.02.006 PMID: 23429008
15. Young M, Funder J (2003) Mineralocorticoid Action and Sodium-Hydrogen Exchange: Studies in Experimental Cardiac Fibrosis. Endocrinology 144: 3848-3851. PMID: 12933657
16. Voelkl J, Lin Y, Alesutan I, AhmedM, Pasham V, Mia S, et al. (2012) Sgk1 sensitivity of Na+/H+ exchanger activity and cardiac remodeling following pressure overload. Basic Research in Cardiology C7-236 107: 1-15. PMID: 2091607
17. Xie Z, Singh M, Singh K (2004) Osteopontin modulates myocardial hypertrophy in response to chronic pressure overload in mice. Hypertension 44: 826-831. PMID: 15534078
18. Renault MA, Robbesyn F, Reant P, Douin V, Daret D, Allieres C, et al. (2010) Osteopontin expression in cardiomyocytes induces dilated cardiomyopathy. Circ Heart Fail 3: 431-439. doi: 10.1161/ CIRCHEARTFAILURE.109.898114 PMID: 20200330
19. Dai J, Matsui T, Abel ED, Dedhar S, Gerszten RE, Seidman CE, et al. (2014) Deep Sequence Analysis of Gene Expression Identifies Osteopontin as a Downstream Effector of Integrin-Linked Kinase (ILK) in Cardiac-Specific ILK Knockout Mice. Circ Heart Fail 7: 184-193. doi: 10.1161/CIRCHEARTFAILURE. 113.000649 PMID: 24319095
20. Wang Y, Chen B, Shen D, Xue S (2009) Osteopontin protects against cardiac ischemia-reperfusion injury through late preconditioning. Heart Vessels 24: 116-123. doi: 10.1007/s00380-008-1094-1 PMID: 19337795
21. Fu GX, Xu CC, Zhong Y, Zhu DL, Gao PJ (2012) Aldosterone-induced osteopontin expression in vascular smooth muscle cells involves MR, ERK, and p38 MAPK. Endocrine 42: 676-683. doi: 10.1007/ s12020-012-9675-2 PMID: 22588951
22. Graf K, Do YS, Ashizawa N, Meehan WP, Giachelli CM, Marboe C, et al. (1997) Myocardial Osteopontin Expression Is Associated With Left Ventricular Hypertrophy. Circulation 96: 3063-3071. PMID: 9386176
23. Diao H, Iwabuchi K, Li L, Onoe K, Van Kaer L, Kon S, et al. (2008) Osteopontin regulates development and function of invariant natural killer T cells. Proc Natl Acad Sci U S A 105: 15884-15889. doi: 10. 1073/pnas.0806089105 PMID: 18836077
24. Nilsson-Berglund LM, Zetterqvist AV, Nilsson-Ohman J, Sigvardsson M, Gonzalez Bosc LV, Smith ML, et al. (2010) Nuclear factor of activated T cells regulates osteopontin expression in arterial smooth muscle in response to diabetes-induced hyperglycemia. Arterioscler Thromb Vasc Biol. United States. pp. 218-224. doi: 10.1161/ATVBAHA.109.199299 PMID: 19965778
25. Guo J, Gan XT, Haist JV, Rajapurohitam V, Zeidan A, Faruq NS, et al. (2011) Ginseng inhibits cardiomyocyte hypertrophy and heart failure via NHE-1 inhibition and attenuation of calcineurin activation. Circ Heart Fail 4: 79-88. doi: 10.1161/CIRCHEARTFAILURE.110.957969 PMID: 20971938
26. Hisamitsu T, Nakamura TY, Wakabayashi S (2012) Na(+)/H(+) exchanger 1 directly binds to calcineurin A and activates downstream NFAT signaling, leading to cardiomyocyte hypertrophy. Mol Cell Biol. United States. pp. 3265-3280.
27. Xie Z, Singh M, Singh K (2004) ERK1/2 and JNKs, but not p38 kinase, are involved in reactive oxygen species-mediated induction of osteopontin gene expression by angiotensin II and interleukin-1beta in adult rat cardiac fibroblasts. J Cell Physiol 198: 399-407. PMID: 14755545
28. Prasad V, Lorenz JN, Miller ML, Vairamani K, Nieman ML, Wang Y, et al. (2013) Loss of NHE1 activity leads to reduced oxidative stress in heart and mitigates high-fat diet-induced myocardial stress. J Mol Cell Cardiol.
29. Chen MZ, Bu QT, Pang SC, Li FL, Sun MN, Chu EF, et al. (2012) Tetrodotoxin attenuates isoprotere-nol-induced hypertrophy in H9c2 rat cardiac myocytes. Mol Cell Biochem 371: 77-88. doi: 10.1007/ s11010-012-1424-6 PMID: 22941212
30. Nakamura TY, Iwata Y, Arai Y, Komamura K, Wakabayashi S (2008) Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure. Circ Res 103: 891-899. doi: 10.1161/CIRCRESAHA.108.175141 PMID: 18776042
31. Louch WE, Sheehan KA, Wolska BM (2011) Methods in cardiomyocyte isolation, culture, and gene transfer. J Mol Cell Cardiol 51: 288-298. doi: 10.1016/j.yjmcc.2011.06.012 PMID: 21723873
32. Watkins SJ, Borthwick GM, Arthur HM (2011) The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro. In Vitro Cell Dev Biol Anim 47: 125-131. doi: 10. 1007/s11626-010-9368-1 PMID: 21082279
33. Ku PM, Chen LJ, Liang JR, Cheng KC, Li YX, Cheng JT, et al. (2011) Molecular role of GATA binding protein 4 (GATA-4) in hyperglycemia-induced reduction of cardiac contractility. Cardiovasc Diabetol 10: 57. doi: 10.1186/1475-2840-10-57 PMID: 21702924
34. Ménard C, Pupier S, Mornet D, Kitzmann M, Nargeot J, Lory P, et al. (1999) Modulation of L-type calcium channel expression during retinoic acid-induced differentiation of H9C2 cardiac cells. J Biol Chem 274: 29063-29070. PMID: 10506158
35. Mraiche F, Oka T, Gan XT, Karmazyn M, Fliegel L (2011) Activated NHE1 is required to induce early cardiac hypertrophy in mice. Basic Res Cardiol 106: 603-616. doi: 10.1007/s00395-011-0161-4 PMID: 21359875
36. Karki P, Coccaro E, Fliegel L (2010) Sustained intracellular acidosis activates the myocardial Na(+)/H(+) exchanger independent of amino acid Ser(703) and p90(rsk). Biochim Biophys Acta 1798: 1565-1576. doi: 10.1016/j.bbamem.2010.05.005 PMID: 20471361
37. Merten KE, Jiang Y, Feng W, Kang YJ (2006) Calcineurin activation is not necessary for Doxorubicininduced hypertrophy in H9c2 embryonic rat cardiac cells: involvement of the phosphoinositide 3-kinase-Akt pathway. J Pharmacol Exp Ther 319: 934-940. PMID: 16926266
38. Xia Y, Javadov S, Gan TX, Pang T, Cook MA, Karmazyn M, et al. (2007) Distinct KATP channels mediate the antihypertrophic effects of adenosine receptor activation in neonatal rat ventricular myocytes. J Pharmacol Exp Ther 320: 14-21. PMID: 17012605
39. Jalvy S, Renault MA, Leen LL, Belloc I, Bonnet J, Gadeau AP, et al. (2007) Autocrine expression of osteopontin contributes to PDGF-mediated arterial smooth muscle cell migration. Cardiovasc Res. Netherlands. pp. 738-747. PMID: 17574222
40. Rittling SR, Feng F (1998) Detection of mouse osteopontin by western blotting. Biochem Biophys Res Commun 250: 287-292. PMID: 9753622
41. Summerton JE (2007) Morpholino, siRNA, and S-DNA compared: impact of structure and mechanism of action on off-target effects and sequence specificity. Curr Top Med Chem 7: 651-660. PMID: 17430206
42. Heineke J, Molkentin JD (2006) Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7: 589-600. PMID: 16936699
43. Coccaro E, Karki P, Cojocaru C, Fliegel L (2009) Phenylephrine and sustained acidosis activate the neonatal rat cardiomyocyte Na+/H+ exchanger through phosphorylation of amino acids Ser770 and Ser771. Am J Physiol Heart Circ Physiol 297: H846-858. doi: 10.1152/ajpheart.01231.2008 PMID: 19542484
44. Kimes BW, Brandt BL (1976) Properties of a clonal muscle cell line from rat heart. Exp Cell Res 98: 367-381. PMID: 943302
45. Kageyama K, Ihara Y, Goto S, Urata Y, Toda G, Yano K, et al. (2002) Overexpression of calreticulin modulates protein kinase B/Akt signaling to promote apoptosis during cardiac differentiation of cardiomyoblast H9c2 cells. J Biol Chem. United States. pp. 19255-19264.
46. Sardao VA, Oliveira PJ, Holy J, Oliveira CR, Wallace KB (2009) Morphological alterations induced by doxorubicin on H9c2 myoblasts: nuclear, mitochondrial, and cytoskeletal targets. Cell Biol Toxicol 25: 227-243. doi: 10.1007/s10565-008-9070-1 PMID: 18386138
47. Pereira SL, Ramalho-Santos J, Branco AF, Sardao VA, Oliveira PJ, Carvalho RA, et al. (2011) Metabolic remodeling during H9c2 myoblast differentiation: relevance for in vitro toxicity studies. Cardiovasc Toxicol 11: 180-190. doi: 10.1007/s12012-011-9112-4 PMID: 21431998
48. Schunke KJ, Coyle L, Merrill GF, Denhardt DT (2013) Acetaminophen attenuates doxorubicin-induced cardiac fibrosis via osteopontin and GATA4 regulation: reduction of oxidant levels. J Cell Physiol 228: 2006-2014. doi: 10.1002/jcp.24367 PMID: 23526585
49. Inoue M, Shinohara ML (2011) Intracellular osteopontin (iOPN) and immunity. Immunol Res 49: 160-172. doi: 10.1007/s12026-010-8179-5 PMID: 21136203
50. Frangogiannis NG (2012) Matricellular proteins in cardiac adaptation and disease. Physiol Rev 92: 635-688. doi: 10.1152/physrev.00008.2011 PMID: 22535894
51. Gao YA, Agnihotri R, Vary CP, Liaw L (2004) Expression and characterization of recombinant osteopontin peptides representing matrix metalloproteinase proteolytic fragments. Matrix Biol 23: 457-466. PMID: 15579312
52. Agnihotri R, Crawford HC, Haro H, Matrisian LM, Havrda MC, Liaw L, et al. (2001) Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin). J Biol Chem 276: 28261-28267. PMID: 11375993
53. Lenga Y, Koh A, Perera A, McCulloch C, Sodek J, Zohar R, et al. (2008) Osteopontin expression is required for myofibroblast differentiation. Circ Res 102: 319-327. PMID: 18079410
54. + exchanger NHE1 through sequence specific interaction. Biochemistry 36: 12854-12861. PMID: 9335543
55. Sodhi CP, Phadke SA, Batlle D, Sahai A (2001) Hypoxia stimulates osteopontin expression and proliferation of cultured vascular smooth muscle cells: potentiation by high glucose. Diabetes 50: 1482-1490. PMID: 11375351
56. Lyle AN, Remus EW, Fan AE, Lassegue B, Walter GA, Kiyosue A, et al. (2013) Hydrogen Peroxide Regulates Osteopontin Expression through Activation of Transcriptional and Translational Pathways. J Biol Chem.
57. Zhao Y, Bachelier R, Treilleux I, Pujuguet P, Peyruchaud O, Baron R, et al. (2007) Tumor alphavbeta3 integrin is a therapeutic target for breast cancer bone metastases. Cancer Res 67: 5821-5830. PMID: 17575150
58. Paradise RK, Lauffenburger DA, Van Vliet KJ (2011) Acidic extracellular pH promotes activation of integrin alpha(v)beta(3). PLoS One 6: e15746. doi: 10.1371/journal.pone.0015746 PMID: 21283814
59. Kazanecki CC, Uzwiak DJ, Denhardt DT (2007) Control of osteopontin signaling and function by posttranslational phosphorylation and protein folding. J Cell Biochem 102: 912-924. PMID: 17910028
60. Nilsson-Berglund LM, Zetterqvist AV, Nilsson-Ohman J, Sigvardsson M, Gonzalez Bosc LV, Smith ML, et al. (2010) Nuclear factor of activated T cells regulates osteopontin expression in arterial smooth muscle in response to diabetes-induced hyperglycemia. Arterioscler Thromb Vasc Biol 30: 218-224. doi: 10.1161/ATVBAHA.109.199299 PMID: 19965778
61. Hisamitsu T, Nakamura TY, Wakabayashi S (2012) Na(+)/H(+) exchanger 1 directly binds to calcineurin A and activates downstream NFAT signaling, leading to cardiomyocyte hypertrophy. Mol Cell Biol 32: 3265-3280. doi: 10.1128/MCB.00145-12 PMID: 22688515
62. Avkiran M, Cook AR, Cuello F (2008) Targeting Na+/H+ exchanger regulation for cardiac protection: a RSKy approach? Curr Opin Pharmacol 8: 133-140. doi: 10.1016/j.coph.2007.12.007 PMID: 18222727
63. Voelkl J, Pasham V, Ahmed MS, Walker B, Szteyn K, Kuhl D, et al. (2013) Sgk1-dependent stimulation of cardiac Na+/H+ exchanger NHE1 by dexamethasone. Cell Physiol Biochem 32: 25-38. doi: 10. 1159/000350120 PMID: 23860121
64. Waller AH, Sanchez-Ross M, Kaluski E, Klapholz M (2010) Osteopontin in cardiovascular disease: a potential therapeutic target. Cardiol Rev 18: 125-131. doi: 10.1097/CRD.0b013e3181cfb646 PMID: 20395697
65. Kilic A, Rajapurohitam V, Sandberg SM, Zeidan A, Hunter JC, Said Faruq N, et al. (2010) A novel chimeric natriuretic peptide reduces cardiomyocyte hypertrophy through the NHE-1-calcineurin pathway. Cardiovasc Res 88: 434-442. doi: 10.1093/cvr/cvq254 PMID: 20679416
66. Doehn U, Hauge C, Frank SR, Jensen CJ, Duda K, Nielsen JV, et al. (2009) RSK is a principal effector of the RAS-ERK pathway for eliciting a coordinate promotile/invasive gene program and phenotype in epithelial cells. Mol Cell 35: 511-522. doi: 10.1016/j.molcel.2009.08.002 PMID: 19716794